Holen Sie sich die Stockscreener-App
0.6344
6.42%
-0.0193
Schlusskurs vom Vortag:
$0.6537
Offen:
$0.667
24-Stunden-Volumen:
68,052
Relative Volume:
0.01
Marktkapitalisierung:
$9.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.12M
KGV:
-0.00583
EPS:
-108.8
Netto-Cashflow:
$-15.86M
1W Leistung:
+12.40%
1M Leistung:
+1.26%
6M Leistung:
-88.16%
1J Leistung:
-90.66%
1-Tages-Spanne:
$0.6099
$0.667
1-Wochen-Bereich:
$0.511
$0.70
52-Wochen-Spanne:
$0.3155
$21.40
Onconetix Inc Stock (ONCO) Company Profile
Firmenname
Onconetix Inc
Sektor
Branche
Telefon
513-620-4101
Adresse
201 E. FIFTH STREET, CINCINNATI
Vergleichen Sie ONCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.62 | 9.51M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.26 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
723.97 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
654.61 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.41 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.89 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Onconetix Inc Aktie (ONCO) Neueste Nachrichten
Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle
Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex
Onconetix files to sell 50M shares of common stock for holders - MSN
Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn
Onconetix faces Nasdaq delisting over share price rule - MSN
Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com
Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire
Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan
ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India
Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Onconetix Inc. (ONCO) reports earnings - Quartz
Onconetix amends forbearance agreement with Veru Inc. - Investing.com
ONCO Stock Hits 52-Week Low at $0.6 Amid Market Challenges - Investing.com Nigeria
ONCO stock touches 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
ONCO stock touches 52-week low at $0.99 amid market challenges - Investing.com
SEC Form 424B4 filed by Onconetix Inc. - Quantisnow
Zurcher Kantonalbank's Strategic Acquisition of Onconetix Inc Sh - GuruFocus.com
ONCO stock touches 52-week low at $2.8 amid market challenges By Investing.com - Investing.com South Africa
ONCO stock touches 52-week low at $2.8 amid market challenges - Investing.com Canada
Onconetix, Inc. (NASDAQ:ONCO) Sees Large Decline in Short Interest - MarketBeat
Onconetix announces change in certifying accountant - Investing.com India
Onconetix announces change in certifying accountant By Investing.com - Investing.com South Africa
Onconetix, Inc. (NASDAQ:ONCO) Short Interest Update - MarketBeat
Onconetix announces financing through $2M private placement - TipRanks
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C - The Bakersfield Californian
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix raises $2 million in private placement - Investing.com
Onconetix Secures Funding to Enhance Operations and Growth - TipRanks
Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewswire
Onconetix Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
What's Going On With Onconetix Shares Friday? - MSN
Investing in Onconetix Inc (ONCO) might be a great opportunity, but the stock is a bit overvalued - US Post News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20% - MSN
Finanzdaten der Onconetix Inc-Aktie (ONCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):